Phytanic acid alpha-oxidation in rat liver mitochondria

Area of Science:

• Biochemistry
• Mitochondrial Metabolism
• Enzyme Kinetics

Background:

• Phytanic acid accumulation causes Refsum's disease.
• Understanding phytanic acid metabolism is crucial for metabolic disorder research.

Purpose of the Study:

• To elucidate the mechanisms of phytanic acid alpha-oxidation in rat liver mitochondria.
• To identify key enzymes and pathways involved in phytanic acid metabolism.

Main Methods:

• Mitochondrial enzyme assays using purified and intact mitochondria.
• Inhibition studies with specific enzyme inhibitors (Naproxen, Triacsin C, POCA, 2-bromopalmitate, cytochrome P-450 inhibitors).
• Analysis of substrate requirements and induction by ciprofibrate.

Main Results:

• Phytanoyl-CoA ligase and carnitine acyltransferase I are essential for phytanic acid activation and mitochondrial transport.
• Alpha-oxidation requires free fatty acid as substrate, unlike beta-oxidation.
• The process is mediated by a cytochrome P-450 enzyme system and induced by ciprofibrate.

Conclusions:

• Rat liver mitochondrial alpha-oxidation of phytanic acid involves specific enzymes and pathways.
• This pathway differs significantly from fatty acid beta-oxidation.
• Findings provide insights into metabolic disorders and potential therapeutic targets.